Accuracy of plasma interleukin-6 and C-reactive protein as markers of sepsis in preterm neonates with respiratory distress syndrome

Aim: To evaluate the diagnostic accuracy of plasma interleukin-6 (IL-6) and serum CRP in detecting blood culture proven sepsis in preterm neonates with respiratory distress syndrome (RDS).Patients and Methods: 140 preterm neonates, 62 with RDS and 78 without RDS, who developed clinical signs of sepsis were prospectively studied. Plasma IL-6 and serum CRP levels were measured. The ROC curves, the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and likelihood ratios (LR) were calculated for IL-6 (> 20 pg/mL and > 80 pg/mL) and CRP (> 10 mg/L).Results: Positive blood cultures were found in 64 neonates (37 with RDS and 27 without RDS). Neonates with RDS had higher IL-6 (p 20 pg/mL was 0,93, 0,65 and 2,68, respectively, in neonates without RDS, and 0,92, 0,16 and 1,09, respectively, in neonates with RDS. The sensitivity, specificity and LR of CRP > 10mg/L were 0,86, 0,71 and 2,97, respectively, in neonates without RDS and 0,73, 0,68 and 2,28, respectively, in neonates with RDS.Conclusions: In neonates without RDS both the IL-6 and CRP are equally accurate markers in diagnosing sepsis, whereas in those with RDS the diagnostic value of IL-6 is limited

The Intertemporal Role of Respiratory Support in Improving Neonatal Outcomes: A Narrative Review

Defining improvements in healthcare can be challenging due to the need to assess multiple outcomes and measures. In neonates, although progress in respiratory support has been a key factor in improving survival, the same degree of improvement has not been documented in certain outcomes, such as bronchopulmonary dysplasia. By exploring the evolution of neonatal respiratory care over the last 60 years, this review highlights not only the scientific advances that occurred with the application of invasive mechanical ventilation but also the weakness of the existing knowledge. The contributing role of non-invasive ventilation and less-invasive surfactant administration methods as well as of certain pharmacological therapies is also discussed. Moreover, we analyze the cost–benefit of neonatal care-respiratory support and present future challenges and perspectives